These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Hemophilic arthropathy. The therapeutic approaches in the clinical picture of hemophilia]. Ambriz-Fernández R; Rodríguez-Moyado H; Villanueva RM; Muñoz-Olvera R; Gacitua-Zambrano S Gac Med Mex; 1991; 127(3):233-9; discussion 239-40. PubMed ID: 1800217 [TBL] [Abstract][Full Text] [Related]
4. Management of haemophilia in Greece. Mandalaki T Thromb Haemost; 1976 Jun; 35(3):522-30. PubMed ID: 989957 [TBL] [Abstract][Full Text] [Related]
5. Haemophilia care in Zimbabwe. Adewuyi JO; Coutts AM; Levy L; Lloyd SE Cent Afr J Med; 1996 May; 42(5):153-6. PubMed ID: 8771937 [TBL] [Abstract][Full Text] [Related]
6. [Emergency therapy and ambulatory care in hemophilia]. Remde W Z Gesamte Inn Med; 1979 Jun; 34(12):154-6. PubMed ID: 315673 [No Abstract] [Full Text] [Related]
7. Management of hemophilia in France. Allain JP Thromb Haemost; 1976 Jun; 35(3):553-8. PubMed ID: 989961 [TBL] [Abstract][Full Text] [Related]
8. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia. McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730 [TBL] [Abstract][Full Text] [Related]
9. The safe blood components for a hemophilia patient: a case report. Chuansumrit A; Pandhawong S; Tardtong P; Isarangkura P Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():198-200. PubMed ID: 7886573 [TBL] [Abstract][Full Text] [Related]
10. [Management of hemophilia]. Laurian Y Rev Prat; 1989 Dec; 39(30):2669-73. PubMed ID: 2515580 [TBL] [Abstract][Full Text] [Related]
11. Substitution treatment of hemophilia a and b. Duckert F Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162 [TBL] [Abstract][Full Text] [Related]
12. [Cellular immunology status in 5 hemophilic patients with inhibitors subjected to massive therapy with factor VIII concentrate]. Aznar JA; Jorquera JI; González Molina A; Carbonell F; Trenor A; Sánchez Cuenca JM; de Andrés R Sangre (Barc); 1983; 28(5):663-4. PubMed ID: 6420915 [No Abstract] [Full Text] [Related]
13. Estimation of the probability of post transfusion hepatitis in hemophilia treatment. Davis CE; Grizzle JE; Bryan JA Biometrics; 1973 Jun; 29(2):386-92. PubMed ID: 4709517 [No Abstract] [Full Text] [Related]
14. [Therapeutic value of cryoprecipitate in hemophilia A]. Lopaciuk S; Szczepański M; Klenowska Z; Daszyński J; Pawelski S Pol Tyg Lek; 1969 Jun; 24(22):829-32. PubMed ID: 4895749 [No Abstract] [Full Text] [Related]
15. Haemophilia in Australia. Rickard KA Thromb Haemost; 1976 Jun; 35(3):566-9. PubMed ID: 989963 [TBL] [Abstract][Full Text] [Related]
17. A hemophilia home care program utilizing cryoprecipitate. Shanberge JN; Kratz NL; Aster RH Scand J Haematol Suppl; 1977; 30():85-6. PubMed ID: 267309 [No Abstract] [Full Text] [Related]
18. [Epidemiology and characteristics of hemophilia in Bulgaria]. Anastassov A; Tankovski I; Nigno C; Guénova V; Lissitchkov T Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(1):113-8. PubMed ID: 4110776 [No Abstract] [Full Text] [Related]
19. Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitors. Lozier JN; Santagostino E; Kasper CK; Teitel JM; Hay CR Semin Hematol; 1993 Apr; 30(2 Suppl 1):10-21. PubMed ID: 8480192 [TBL] [Abstract][Full Text] [Related]
20. Specific therapy in hemophilia. Hutaff LW N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809 [No Abstract] [Full Text] [Related] [Next] [New Search]